Contract SPE2DP18F6022
Glaxosmithkline, Llc · Department Of Defense · September 24, 2018
Glaxosmithkline, Llc was awarded a federal contract by Department Of Defense (Defense Logistics Agency) on September 24, 2018 for $10,000 of work in pharmaceutical preparation manufacturing. Performance is in Durham, NC. This is a task or delivery order issued under parent IDIQ SPE2DP18D0010. It uses firm fixed-price contract pricing.
Contract details
- PIID
- SPE2DP18F6022
- Parent IDIQ
- SPE2DP18D0010
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Durham, NC
- First action
- September 24, 2018
Description
8505904284!ZANAMIVIR FOR INHAL
Modification timeline
-
September 24, 2018Base award$9.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract SPE2DP18F6022?
Contract SPE2DP18F6022 is a federal contract awarded to Glaxosmithkline, Llc by Department Of Defense on September 24, 2018 for $10,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract SPE2DP18F6022?
Glaxosmithkline, Llc won contract SPE2DP18F6022 from Department Of Defense.
How much is contract SPE2DP18F6022 worth?
Contract SPE2DP18F6022 has obligated $10,000 to date.